Article Information
History
- August 11, 2020.
Article Versions
- Version 1 (May 25, 2020 - 02:12).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Maurice M Nigo1,4,8,
- Peter Odermatt3,5,
- David Wully Nigo6,8,
- Georgette B. Salieb-Beugelaar1,
- Manuel Battegay3,7 and
- Patrick R Hunziker1,2,3,*
- 1Nanomedicine Translation Group, Medical Intensive Care Clinic, University Hospital Basel University of Basel, Petersgraben 4, CH-4031 Basel, Switzerland
- 2CLINAM - European Foundation for Clinical Nanomedicine, Alemannengasse 12, P.O. Box, CH-4016 Basel, Switzerland
- 3University of Basel, Petersplatz 1, Basel, Switzerland
- 4Institut Supérieur des Techniques Médicales (ISTM) Nyankunde, B.P. 55 Bunia, Democratic Republic of Congo
- 5Swiss Tropical and Public Health Institute, Socinstrasse 57, P.O. Box, CH-4002 Basel, Switzerland
- 6Centre Hospitalier, Ingbokolo Town, Democratic Republic of Congo
- 7Department of Infectiology & Hospital Hygiene, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland
- 8Circonflex Foundation, Bunia, DR Congo
- ↵*corresponding author: patrick.hunziker{at}usb.ch
Posted August 11, 2020.
Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo
